Dynatrace Inc
For the period ended Mar 31, 2025. Filed May 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 22, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Report of Independent Registered Public Accounting Firm
To the Shareholders and the Board of Directors of Dynatrace, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Dynatrace, Inc. (the Company) as of March 31, 2025 and 2024, the related consolidated statements of operations, comprehensive income, shareholders’ equity and cash flows for each of the three years in the period ended March 31, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at March 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2025, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of March 31, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated May 22, 2025 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
| Revenue Recognition – Determination of Distinct Performance Obligations | |
| Description of the Matter | As described in Note 2 to the consolidated financial statements, the Company enters into contracts with customers that may include promises to transfer software licenses, subscription services, maintenance and support for software licenses, and professional services.Given the nature of the Company’s product and service offerings, there is complexity in determining whether software licenses and services are considered performance obligations that should be accounted for separately or together. Auditing the Company’s determination of distinct performance obligations related to its various product and service offerings involved a high degree of judgment. Specifically, significant auditor judgment was required when assessing whether the when-and-if available updates included within the Company’s maintenance agreements and the related software licenses should be accounted for as separate performance obligations or as inputs to a combined performance obligation. |
|---|
| How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of internal controls over the Company’s processes as they relate to the determination of distinct performance obligations within contracts with customers. Among other audit procedures, we selected a sample of contracts and evaluated whether management appropriately identified and considered whether the contract had (1) multiple promised products or services that constitute separate performance obligations or (2) a single performance obligation that is comprised of combined products and/or services. To evaluate management’s conclusion that when-and-if available updates included within the Company’s maintenance agreements are critical to the continued utility of the related software licenses such that they should be accounted together as inputs to a combined performance obligation, we obtained an understanding of the nature and importance of the updates, assessed the impact and frequency of updates, and reviewed information around the updates included on the Company’s website and marketing materials. |
|---|---|
| Income Taxes – Valuation of Transferred IP | |
| Description of the Matter | As described in Note 9 to the consolidated financial statements, during the year ended March 31, 2025, the Company completed an intra-entity asset transfer of global economic rights of certain intellectual property assets (“IP”). The transaction resulted in a step-up of tax-deductible basis in the transferred assets, and accordingly, created a temporary difference where the tax basis exceeded the financial statement basis of such intangible assets, which resulted in the recognition of a discrete tax benefit and related deferred tax asset of $320.9 million. The Company determined the estimated value of the IP based principally on the present value of projected income related to the IP, requiring management to estimate discount rates and the forecast of future revenues. Auditing discount rates and the forecast of future revenue assumptions used in the valuation of the IP required a high degree of judgment and an increased extent of effort, including the need to involve our tax transfer pricing specialists, when performing audit procedures to evaluate the reasonableness of management’s methodologies, estimates and assumptions related to the selection of the discount rates and forecasts of future revenues. |
| How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of internal controls over the Company’s processes as they relate to the valuation of the intra-entity IP transfer, including management’s selection of the discount rates and forecasts of future revenue. Among other audit procedures, we evaluated the reasonableness of the discount rates with the assistance from our tax transfer pricing specialist, including testing the source information underlying the determination of the discount rate and the mathematical accuracy of the calculation. We evaluated the reasonableness of management’s forecasts of revenue by comparing the forecasts to (1) historical results, (2) comparable guideline public companies, and (3) industry reports. |
/s/ Ernst & Young LLP
We have served as the Company’s auditor since 2022.
Detroit, Michigan
May 22, 2025
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
| March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $1,017,039 | $778,983 |
| Short-term investments | 96,189 | 57,891 |
| Accounts receivable, net | 624,437 | 602,739 |
| Deferred commissions, current | 109,895 | 98,935 |
| Prepaid expenses and other current assets | 83,901 | 66,749 |
| Total current assets | 1,931,461 | 1,605,297 |
| Long-term investments | 51,648 | 46,350 |
| Property and equipment, net | 61,522 | 53,325 |
| Operating lease right-of-use asset, net | 67,479 | 61,390 |
| Goodwill | 1,336,435 | 1,335,494 |
| Intangible assets, net | 25,534 | 50,995 |
| Deferred tax assets, net | 529,550 | 138,836 |
| Deferred commissions, non-current | 95,297 | 93,310 |
| Other assets | 40,752 | 24,782 |
| Total assets | $4,139,678 | $3,409,779 |
| Liabilities and shareholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $27,286 | $21,410 |
| Accrued expenses, current | 252,503 | 233,675 |
| Deferred revenue, current | 1,087,518 | 987,953 |
| Operating lease liabilities, current | 13,979 | 15,513 |
| Total current liabilities | 1,381,286 | 1,258,551 |
| Deferred revenue, non-current | 50,989 | 62,308 |
| Accrued expenses, non-current | 24,452 | 18,404 |
| Operating lease liabilities, non-current | 61,384 | 54,013 |
| Deferred tax liabilities | 419 | 1,013 |
| Total liabilities | 1,518,530 | 1,394,289 |
| Commitments and contingencies (Note 13) | ||
| Shareholders' equity: | ||
| Common shares, $0.001 par value, 600,000,000 shares authorized, 299,813,048 and 296,962,547 shares issued and outstanding at March 31, 2025 and 2024, respectively | 300 | 297 |
| Additional paid-in capital | 2,370,563 | 2,249,349 |
| Retained earnings (accumulated deficit) | 284,927 | (198,757) |
| Accumulated other comprehensive loss | (34,642) | (35,399) |
| Total shareholders' equity | 2,621,148 | 2,015,490 |
| Total liabilities and shareholders' equity | $4,139,678 | $3,409,779 |
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Revenue: | |||
| Subscription | $1,622,163 | $1,359,354 | $1,083,330 |
| Service | 76,520 | 71,176 | 75,200 |
| Total revenue | 1,698,683 | 1,430,530 | 1,158,530 |
| Cost of revenue: | |||
| Cost of subscription | 233,299 | 184,765 | 144,445 |
| Cost of service | 73,631 | 65,423 | 62,882 |
| Amortization of acquired technology | 13,262 | 16,265 | 15,564 |
| Total cost of revenue | 320,192 | 266,453 | 222,891 |
| Gross profit | 1,378,491 | 1,164,077 | 935,639 |
| Operating expenses: | |||
| Research and development | 384,572 | 304,739 | 218,349 |
| Sales and marketing | 605,599 | 534,233 | 448,015 |
| General and administrative | 195,347 | 174,412 | 150,172 |
| Amortization of other intangibles | 13,540 | 22,293 | 26,292 |
| Total operating expenses | 1,199,058 | 1,035,677 | 842,828 |
| Income from operations | 179,433 | 128,400 | 92,811 |
| Interest income (expense), net | 48,281 | 37,284 | (3,409) |
| Other (expense) income, net | (4,285) | (10,769) | 565 |
| Income before income taxes | 223,429 | 154,915 | 89,967 |
| Income tax benefit (expense) | 260,255 | (283) | 17,992 |
| Net income | $483,684 | $154,632 | $107,959 |
| Net income per share: | |||
| Basic | $1.62 | $0.53 | $0.38 |
| Diluted | $1.59 | $0.52 | $0.37 |
| Weighted average shares outstanding: | |||
| Basic | 298,384 | 294,051 | 287,700 |
| Diluted | 303,602 | 299,280 | 291,617 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net income | $483,684 | $154,632 | $107,959 |
| Other comprehensive income (loss) | |||
| Foreign currency translation adjustment | 380 | (3,397) | (5,140) |
| Unrealized gains (losses) on available-for-sale investments, net of taxes | 377 | (173) | — |
| Total other comprehensive income (loss) | 757 | (3,570) | (5,140) |
| Comprehensive income | $484,441 | $151,062 | $102,819 |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
| Common Shares · AdditionalPaid-In Capital · (Accumulated Deficit) Retained Earnings · AccumulatedOtherComprehensiveLoss · Shareholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | |||||
| Balance, March 31, 2022 | 286,053 | $286 | $1,792,197 | $(461,348) | $(26,689) | $1,304,446 |
| Other comprehensive loss | — | — | — | — | (5,140) | (5,140) |
| Restricted stock units vested | 2,139 | 2 | (2) | — | — | — |
| Restricted stock awards forfeited | (15) | — | — | — | — | — |
| Issuance of common stock related to employee stock purchase plan | 553 | — | 17,806 | — | — | 17,806 |
| Exercise of stock options | 1,681 | 2 | 32,937 | — | — | 32,939 |
| Share-based compensation | — | — | 146,874 | — | — | 146,874 |
| Equity repurchases | — | — | (15) | — | — | (15) |
| Net income | — | — | — | 107,959 | — | 107,959 |
| Balance, March 31, 2023 | 290,411 | $290 | $1,989,797 | $(353,389) | $(31,829) | $1,604,869 |
| Other comprehensive loss | — | — | — | — | (3,570) | (3,570) |
| Restricted stock units vested | 4,376 | 4 | (4) | — | — | — |
| Restricted stock awards granted | 142 | — | — | — | — | — |
| Issuance of common stock related to employee stock purchase plan | 534 | 1 | 19,471 | — | — | 19,472 |
| Exercise of stock options | 1,500 | 2 | 31,189 | — | — | 31,191 |
| Share-based compensation | — | — | 208,896 | — | — | 208,896 |
| Net income | — | — | — | 154,632 | — | 154,632 |
| Balance, March 31, 2024 | 296,963 | $297 | $2,249,349 | $(198,757) | $(35,399) | $2,015,490 |
| Other comprehensive income | — | — | — | — | 757 | 757 |
| Restricted stock units vested | 5,228 | 5 | (5) | — | — | — |
| Issuance of common stock related to employee stock purchase plan | 531 | — | 21,159 | — | — | 21,159 |
| Exercise of stock options | 932 | 1 | 20,994 | — | — | 20,995 |
| Share-based compensation | — | — | 271,703 | — | — | 271,703 |
| Shares withheld for employee taxes | (394) | — | (20,022) | — | — | (20,022) |
| Repurchases of common stock | (3,447) | (3) | (172,615) | — | — | (172,618) |
| Net income | — | — | — | 483,684 | — | 483,684 |
| Balance, March 31, 2025 | 299,813 | $300 | $2,370,563 | $284,927 | $(34,642) | $2,621,148 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net income | $483,684 | $154,632 | $107,959 |
| Adjustments to reconcile net income to cash provided by operations: | |||
| Depreciation | 19,236 | 15,499 | 12,541 |
| Amortization | 28,868 | 39,441 | 42,070 |
| Share-based compensation | 271,703 | 208,896 | 146,874 |
| Loss on extinguishment of debt | — | — | 5,925 |
| Deferred income taxes | (392,942) | (59,915) | (53,534) |
| Other | 2,035 | 11,216 | 988 |
| Net change in operating assets and liabilities: | |||
| Accounts receivable | (24,026) | (161,888) | (94,910) |
| Deferred commissions | (14,648) | (23,520) | (45,191) |
| Prepaid expenses and other assets | (36,593) | (47,401) | 26,753 |
| Accounts payable and accrued expenses | 31,534 | 37,896 | 58,680 |
| Operating leases, net | (231) | 1,026 | 1,186 |
| Deferred revenue | 90,799 | 202,227 | 145,544 |
| Net cash provided by operating activities | 459,419 | 378,109 | 354,885 |
| Cash flows from investing activities: | |||
| Purchase of property and equipment | (26,106) | (26,459) | (21,540) |
| Capitalized software additions | (2,696) | (5,268) | — |
| Acquisition of businesses, net of cash acquired | (100) | (57,111) | — |
| Purchases of investments | (145,555) | (104,210) | — |
| Sales and maturities of investments | 105,142 | — | — |
| Net cash used in investing activities | (69,315) | (193,048) | (21,540) |
| Cash flows from financing activities: | |||
| Repayment of term loans | — | — | (281,125) |
| Debt issuance costs | — | — | (1,949) |
| Payments of deferred consideration related to capitalized software additions | (2,208) | — | — |
| Proceeds from employee stock purchase plan | 21,159 | 19,472 | 17,806 |
| Proceeds from exercise of stock options | 20,995 | 31,191 | 32,939 |
| Repurchases of common stock | (172,618) | — | — |
| Taxes paid related to net share settlement of equity awards | (18,958) | — | — |
| Equity repurchases | — | — | (15) |
| Net cash (used in) provided by financing activities | (151,630) | 50,663 | (232,344) |
| Effect of exchange rates on cash and cash equivalents | (418) | (12,089) | (8,620) |
| Net increase in cash and cash equivalents | 238,056 | 223,635 | 92,381 |
| Cash and cash equivalents, beginning of year | 778,983 | 555,348 | 462,967 |
| Cash and cash equivalents, end of year | $1,017,039 | $778,983 | $555,348 |
| Supplemental cash flow data: | |||
| Cash paid for interest | $753 | $851 | $7,109 |
| Cash paid for (received from) tax, net | $117,979 | $81,360 | $(14,311) |
| Non-cash investing and financing activities: | |||
| Capitalized software additions in accounts payable and accrued expenses | $567 | $6,073 | $— |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- Description of the Business
Business
Dynatrace, Inc. (“Dynatrace” or the “Company”) is advancing observability for today’s digital businesses, helping to transform the complexity of modern digital ecosystems into powerful business assets. By leveraging artificial intelligence (“AI”)-powered insights, Dynatrace enables organizations to analyze, automate, and innovate faster to drive their business forward. The Company’s comprehensive solution combines broad and deep observability, continuous runtime application security, and advanced AI to support IT operations, development, security, and business teams, enabling organizations to optimize cloud and IT operations, accelerate secure software delivery, and improve digital performance.
Fiscal year
The Company’s fiscal year ends on March 31. References to fiscal 2025, for example, refer to the fiscal year ended March 31, 2025.
- Significant Accounting Policies
Basis of presentation and consolidation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding financial reporting. All intercompany balances and transactions have been eliminated in the accompanying consolidated financial statements.
Foreign currency translation
The reporting currency of the Company is the U.S. dollar. The functional currency of the Company’s principal foreign subsidiaries is the currency of the country in which each entity operates. Accordingly, assets and liabilities in the consolidated balance sheets have been translated at the rate of exchange at the balance sheet date, and revenues and expenses have been translated at average exchange rates prevailing during the period the transactions occurred. Translation adjustments have been excluded from the results of operations and are reported as accumulated other comprehensive loss within the consolidated statements of shareholders’ equity.
Transaction gains and losses generated by the effect of changes in foreign currency exchange rates on recorded assets and liabilities denominated in a currency different than the functional currency of the applicable entity are recorded in “Other (expense) income, net” in the consolidated statements of operations.
Use of estimates
The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Management evaluates such estimates and assumptions for continued reasonableness. In particular, the Company makes estimates with respect to the stand-alone selling price for each distinct performance obligation in customer contracts with multiple performance obligations, the allowance for credit losses, the fair value of assets acquired and liabilities assumed in business combinations, the valuation of long-lived assets, the valuation of intellectual property (“IP”), the period of benefit for deferred commissions, income taxes, equity-based compensation expense, and the determination of the incremental borrowing rate used for operating lease liabilities, among other things. Management bases these estimates on historical experiences and on various other assumptions that the Company believes are reasonable. Actual results could differ from those estimates.
Segment information
The Company hasone operating and reportable segment. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer, who reviews financial information presented on a consolidated basis, for purposes of making operating decisions, assessing financial performance and allocating resources.
Business combinations
When the Company acquires a business, management allocates the fair value of the purchase price to the assets acquired and liabilities assumed. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded as goodwill. Determining the fair values of identifiable assets and liabilities requires management to make estimates and assumptions, especially with respect to intangible assets. These estimates can include, but are not limited to, future expected cash flows, expected asset lives, discount rates, revenue growth rates, and royalty rates. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of assets acquired and liabilities assumed, with the corresponding offset to goodwill. Acquisition-related transactions are expensed as incurred.
Revenue recognition
The Company sells subscriptions, software licenses, maintenance and support, and professional services together in contracts with its customers, which include end-customers and channel partners. The Company’s software license agreements provide customers with a right to use software for a defined term. As required under applicable accounting principles, the goods and services that the Company promises to transfer to a customer are accounted for separately if they are distinct from one another. Promised items that are not distinct are bundled as a combined performance obligation. The transaction price is allocated to the performance obligations based on the relative estimated standalone selling prices of those performance obligations.
The Company determines revenue recognition through the following steps:
- Identification of the contract, or contracts, with a customer
The Company considers the terms and conditions of the contract in identifying the contracts. The Company determines a contract with a customer to exist when the contract is approved, each party’s rights regarding the services to be transferred can be identified, the payment terms for the services can be identified, it has been determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company will evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. The Company applies judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit, and financial information pertaining to the customer.
- Identification of the performance obligations in the contract
Performance obligations promised in a contract are identified based on the services and the products that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract. In identifying performance obligations, the Company reviews contractual terms, considers whether any implied rights exist, and evaluates published product and marketing information. The Company’s performance obligations consist of (a) subscription services; (b) software licenses; (c) maintenance and support for software licenses; and (d) professional services.
- Determination of the transaction price
The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. The Company’s contracts do not contain a significant financing component.
- Allocation of the transaction price to the performance obligations in the contract
If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price (“SSP”) for arrangements not including subscription services or software licenses. The Company has determined that its pricing for subscription services and software licenses is highly variable and therefore allocates the transaction price to those performance obligations using the residual approach.
- Recognition of revenue when, or as a performance obligation is satisfied
Revenue is recognized at the time the related performance obligation is satisfied by transferring the control of the promised service to a customer. Revenue is recognized when control of the service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services.
Subscription revenue relates to performance obligations for which the Company recognizes revenue over time as control of the product or service is transferred to the customer. Subscription revenue is derived from (i) SaaS arrangements that permit customers to access and utilize the Company’s platform on a hosted basis and (ii) arrangements where the software is delivered and used on-premise as term-based licenses, both of which are sold with maintenance. The when-and-if available updates of the Dynatrace platform, which are part of the maintenance agreement, are critical to the continued utility of the Dynatrace platform; therefore, the Company has determined the Dynatrace platform and the related when-and-if available updates to be a combined performance obligation. Subscription revenues from the performance obligations when sold as a SaaS arrangement are generally recognized ratably over the term of the arrangement. When the platform is sold as a term-based license, the revenue for the combined performance obligation is recognized ratably over the license term as maintenance is included for the duration of the license term.
Service
The Company offers implementation, consulting and training services for the Company’s software solutions and SaaS offerings. Services fees are generally based on hourly rates. Revenues from services are recognized in the period the services are performed, provided that collection of the related receivable is reasonably assured.
Deferred commissions
Deferred sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions for new contracts are deferred and then amortized on a straight-line basis over a period of benefit which the Company has estimated to bethree years. The period of benefit has been determined by taking into consideration the duration of customer contracts, the life of the technology, renewals of maintenance and other factors. Sales commissions for renewal contracts are deferred and then amortized on a straight-line basis over a period of benefit which the Company has estimated to bethree years. Amortization expense is included in “Sales and marketing” expenses on the consolidated statements of operations.
The Company periodically reviews these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred commissions. There wereno impairment losses recorded during the periods presented.
Deferred revenue
Deferred revenue consists primarily of billed subscription fees related to the future service period of subscription agreements in effect at the reporting date. Short-term deferred revenue represents the unearned revenue that will be earned within 12 months of the balance sheet date. Long-term deferred revenue represents the unearned revenue that will be earned after 12 months from the balance sheet date.
Payment terms
Payment terms and conditions vary by contract type, although the Company’s terms generally include a requirement of payment within 30 to 60 days. In instances where the timing of revenue recognition differs from the timing of payment, the Company has determined that its contracts do not include a significant financing component. The primary purpose of invoicing terms is to provide customers with simplified and predictable ways of purchasing products and services, not to receive financing from customers or to provide customers with financing.
Contract modifications
Contract modifications are assessed to determine (i) if the additional goods and services are distinct from the goods and services in the original arrangement; and (ii) if the amount of the consideration expected for the added goods and services reflects the SSP of those goods and services, as adjusted for contract-specific circumstances. The Company’s additional goods and services offered have historically been distinct. A contract modification meeting both criteria is accounted for as a separate contract. A contract modification not meeting both criteria is considered a change to the original contract, which the Company accounts for on a prospective basis as the termination of the existing contract and the creation of a new contract.
Research and development costs are expensed as incurred. Research and development costs primarily include the cost of programming personnel, including share-based compensation, deprecation of equipment, and facilities- and IT-related expenses.
Advertising
Advertising costs are expensed as incurred and are included in “Sales and marketing” expense in the consolidated statements of operations. Advertising expense was $32.7 million, $37.7 million, and $36.2 million during the years ended March 31, 2025, 2024 and 2023, respectively.
Leases
Leases arise from contractual obligations that convey the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. At the inception of the contract, the Company determines if an arrangement contains a lease based on whether there is an identified asset and whether the Company controls the use of the identified asset. The Company also determines the classification of that lease, between financing and operating, at the lease commencement date. The Company accounts for and allocates consideration to the lease and non-lease components as a single lease component.
A right-of-use asset represents the Company’s right to use an underlying asset for the lease term and a lease liability represents the Company’s obligation to make payments during the lease term. Right-of-use assets are recognized at the lease commencement date for the lease liability, adjusted for initial direct costs incurred and lease incentives received. Lease liabilities are recorded at the present value of the future lease payments over the lease term. The discount rate used to determine the present value is the incremental borrowing rate as the implicit rate for the operating leases is generally not determinable. The Company determines the incremental borrowing rate of the leases by considering various factors, such as the credit rating, interest rates of similar debt instruments of entities with comparable credit ratings, jurisdictions, and the lease term.
The Company’s lease terms may include options to extend or terminate the lease. The Company generally uses the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that the Company will exercise those options. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The Company does not record leases with terms of 12 months or less on the consolidated balance sheets. Lease expense is recognized on a straight-line basis over the expected lease term.
Concentration of credit risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, investments and accounts receivable.
The Company maintains the majority of its cash, cash equivalents and investments with major financial institutions that the Company believes to be of high credit standing. The Company maintains its cash in bank deposit accounts that, at times, may exceed federally insured limits.
The Company provides credit to customers in the normal course of business. The Company’s customer base consists of a large number of geographically-dispersed customers across multiple industries.
As of March 31, 2025 and 2024, there wasone channel partner with a balance greater than 10% of accounts receivable. No end- customers had a balance greater than 10% of the Company’s accounts receivable as of March 31, 2025 and 2024. For the year ended March 31, 2025, one channel partner accounted for 10% of revenue. No channel partners accounted for 10% or more of revenue for the years ended March 31, 2024 and 2023. There were no end-customers who represented 10% or more of revenue for the years ended March 31, 2025, 2024, and 2023.
Cash and cash equivalents
All highly liquid investments with an original maturity of three months or less when purchased are considered cash and cash equivalents.
Investments
The Company’s investments consist of commercial paper, corporate debt securities, U.S. government agency securities, and U.S. treasury securities. These investments are classified as available-for-sale and recorded at fair value in the consolidated balance sheet.
Premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield. Interest income is recognized when earned.
Unrealized gains and losses on available-for-sale investments, net of tax, are included within accumulated other comprehensive loss in the consolidated balance sheets. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as credit ratings, issuer-specific factors, current economic conditions, and reasonable and supportable forecasts. The Company does not intent to sell these investments and it is more likely than not that the Company will not be required to sell these investments before recovery of their amortized cost basis. Based on the evaluation of available evidence, the Company does not believe any unrealized losses on its investments as of March 31, 2025 represent credit losses.
Realized gains and losses from the sales of available-for-sale investments are based on the specific identification method and are recorded in the consolidated statement of income as “Other (expense) income, net”.
Accounts receivable, net
Accounts receivable are recorded at the invoiced amount, net of allowance for credit losses. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors. In establishing any required allowance, management considers historical losses adjusted for current market conditions, the Company’s customers’ financial condition, the amount of any receivables in dispute, the current receivables aging, current payment terms and expectations of forward-looking loss estimates. Allowance for credit losses was $3.5 million and $4.5 million as of March 31, 2025 and 2024, respectively.
Property and equipment, net
The Company records property and equipment, net, at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the related assets. The following table presents the estimated useful lives of the Company’s property and equipment:
| Computer equipment and software | 3 - 5 years |
|---|---|
| Furniture and fixtures | 5 - 10 years |
| Leasehold improvements | Lesser of 10 years or the lease term |
Goodwill and intangible assets
Goodwill represents the excess of the purchase price of an acquired business over the fair value of the assets acquired and liabilities assumed. Goodwill is evaluated for impairment annually and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. The Company has elected to first assess the qualitative factors to determine if it is more likely than not that the fair value of the underlying assets is less than its carrying amount. If the Company determines that it is more likely than not that the underlying assets’ fair value is less than its carrying amount in the qualitative analysis, then a quantitative goodwill impairment test will be performed by comparing the fair value of the assets to their carrying value. For the purposes of impairment testing, the Company is evaluated asone reporting unit.
Intangible assets consist primarily of customer relationships, developed technology, tradenames and trademarks, all of which have a finite useful life. Intangible assets are amortized based on either the pattern in which the economic benefits of the intangible assets are estimated to be realized or on a straight-line basis, which approximates the manner in which the economic benefits of the intangible asset will be consumed.
There wasno impairment of goodwill during the years ended March 31, 2025, 2024 and 2023.
Capitalized software
Software development costs associated with software developed, acquired or modified for internal use is capitalized. Costs incurred during the preliminary planning and evaluation stage of the project and during the post implementation stages of the project are expensed as incurred. Costs incurred during the application development stage of the project are capitalized. These capitalized costs consist of internal compensation related costs and direct external costs. The amortization period for these capitalized costs is generally three tofive years depending on the project.
During the year ended March 31, 2024, the Company entered into a license agreement with an application security provider, resulting in $10.3 million of capitalized costs related to software developed for internal use. During the years ended March 31, 2025 and 2023, the Company didnot capitalize costs for software developed for internal use. Amortization of software developed for internal use was $2.1 million, $0.9 million, and $0.2 million during the years ended March 31, 2025, 2024 and 2023, respectively, and is recorded within “Cost of subscription” in the consolidated statements of operations.
Costs related to software developed for sale are expensed as research and development until technological feasibility has been established for the product. Once technological feasibility has been established for the product, all software costs are capitalized until the product is available for general release to customers. To date, the software development costs have not been capitalized as the cost incurred and time between technological feasibility and general product release was insignificant. As such, these costs are expensed as incurred and recorded in “Research and development” in the consolidated statements of operations.
Impairment of long-lived assets
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by an asset to the carrying value of the asset. If the carrying value of the long-lived asset is not recoverable on an undiscounted cash flow basis, impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is estimated by the Company using discounted cash flows and other market- related valuation models, including earnings multiples and comparable asset market values. The Company hasnot incurred any impairment losses during the years ended March 31, 2025, 2024 and 2023.
Income taxes
The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the consolidated financial statements and income tax bases of assets and liabilities and net operating loss and tax credit carryforwards using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period that includes the enactment date. The Company records deferred tax liabilities that arise from outside basis differences in foreign subsidiaries that are not considered indefinitely reinvested.
Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some or all of the deferred taxes will not be realized. In making such determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations.
The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that that the tax positions will be sustained on the basis of the technical merits of the position; and (2) for those tax positions that meet the more likely than not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line the accompanying consolidated statement of operations.
The Company treats Global Intangible Low Taxed Income ("GILTI") as a period cost.
Fair value of assets and liabilities
Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. The hierarchical levels are as follows:
Level 1: Observable inputs that reflect quoted prices for identical assets or liabilities in active markets;
Level 2: Observable inputs, other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3: Unobservable inputs reflecting the Company’s own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
The Company’s financial instruments including accounts receivable, accounts payable and other current liabilities are stated at their carrying value, which approximates their fair values due to their short maturities.
Share-based compensation
The Company measures the cost of employee services received in exchange for an award of equity instruments, including stock options, restricted stock awards (“RSAs”), time-based, performance-based and market-based restricted stock units (“RSUs”), and the purchase rights under the employee stock purchase plan (the “ESPP”), based on the estimated grant-date fair value of the award. The Company calculates the fair value of stock options and the purchase rights under the ESPP using the Black-Scholes option-pricing model. This requires the input of assumptions, including the fair value of the Company’s underlying common stock, the expected term of stock options and purchase rights, the expected volatility of the price of the Company’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock. The fair value of time-based and performance-based RSAs and RSUs is determined by the closing price on the date of grant of the Company’s common stock. The Company calculates the fair value of market-based RSUs using the Monte Carlo simulation model. This requires the input of assumptions, including the fair value of the Company’s underlying common stock, the expected performance period of the award, the expected volatility of the price of the Company’s and peer group’s common stock, risk-free interest rates, and the expected dividend yield of the Company’s common stock.
The Company recognizes share-based compensation expense following the straight-line attribution method over the requisite service period of the entire award for stock options, RSAs and RSUs; and over the offering period for the purchase rights issued under the ESPP. For RSUs that vest based upon continued service and achievement of certain performance conditions, share-based compensation expense is recognized over the requisite service period following the accelerated attribution method based upon the probability that the performance condition will be satisfied. For RSUs that vest based upon continued service and achievement of certain market conditions, share-based compensation expense is recognized following the accelerated attribution method over the requisite service period. Forfeitures are accounted for in the period in which the awards are forfeited.
Net income per share
Basic net income per share is calculated by dividing the net income for the period by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed by giving effect to all potentially dilutive securities, including stock options, RSUs, RSAs, and the impact of the purchase rights of the ESPP.
Recently adopted accounting pronouncements
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and application of all segment disclosure requirement to entities with a single reportable segment. ASU 2023-07 is effective for the Company’s annual periods beginning fiscal 2025 and interim periods beginning the first quarter of fiscal 2026. Effective March 31, 2025, the Company adopted the new standard on a retrospective basis. For further information, refer to Note 18, Segment and Geographic Information.
Recently issued accounting pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in the income tax rate reconciliation table and disaggregates the income taxes paid by jurisdiction. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024, which will be the Company’s fiscal 2026. The Company is currently evaluating the impact ASU 2023-09 will have on its financial statement disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires the disclosure of more detailed information on commonly presented expenses. ASU 2024-03 will be effective for the Company’s annual periods beginning fiscal 2028 and interim periods beginning the first quarter of fiscal 2029. The Company is currently evaluating the impact ASU 2024-03 will have on its financial statement disclosures.
- Revenue Recognition
Disaggregation of revenue
The following table is a summary of the Company’s total revenue by geographic region based on the Company’s contracting entity (in thousands, except percentages):
| Fiscal Year Ended March 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| Amount | % | Amount | % | Amount | % | |
| North America | $1,036,664 | 61% | $852,497 | 60% | $690,899 | 60% |
| Europe, Middle East and Africa | 407,200 | 24% | 354,793 | 25% | 292,176 | 25% |
| Asia Pacific | 151,414 | 9% | 130,611 | 9% | 111,339 | 10% |
| Latin America | 103,405 | 6% | 92,629 | 6% | 64,116 | 5% |
| Total revenue | $1,698,683 | $1,430,530 | $1,158,530 | |||
For the years ended March 31, 2025, 2024, and 2023, the United States was the only country that represented more than 10% of the Company’s revenues in any period, constituting $987.2 million and 58%, $807.7 million and 56%, and $652.0 million and 56% of total revenue, respectively.
Deferred commissions
The following table represents a rollforward of the Company’s deferred commissions (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Beginning balance | $192,245 | $169,261 | $126,036 |
| Additions to deferred commissions | 131,510 | 121,100 | 119,233 |
| Amortization of deferred commissions | (118,563) | (98,116) | (76,008) |
| Ending balance | $205,192 | $192,245 | $169,261 |
Deferred revenue
Revenue recognized during the years ended March 31, 2025, 2024, and 2023 which was included in the deferred revenue balances at the beginning of each respective period was $975.7 million, $800.0 million, and $670.1 million.
Remaining performance obligations
As of March 31, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations was $2,892.7 million, which consists of both billed consideration in the amount of $1,138.5 million and unbilled consideration in the amount of $1,754.2 million that the Company expects to recognize as subscription and service revenue. The Company expects to recognize 53% of this amount as revenue in the year ending March 31, 2026 and the remainder thereafter.
Contract assets
As of March 31, 2025 and March 31, 2024, contract assets of $1.6 million and $5.2 million, respectively, are included in accounts receivable, net, on the Company’s consolidated balance sheets.
- Business Combinations
Rookout, Ltd.
On August 31, 2023, the Company acquired 100% of the outstanding equity of Rookout, Ltd. (“Rookout”), a provider of enterprise-ready and privacy-aware solutions that enable developers to troubleshoot and debug actively running code in Kubernetes-hosted cloud-native applications. This acquisition expanded the Company’s platform from the addition of Rookout’s technology and experienced team. The purchase consideration of Rookout was $33.4 million, after considering certain adjustments, and was paid from cash on hand.
The fair value of the purchase price was allocated to the identifiable assets acquired and liabilities assumed as of the acquisition date, with the excess recorded to goodwill. The Company acquired $6.0 million of net assets, including $7.8 million of intangible assets, resulting in goodwill of $27.4 million. The fair value of acquired assets and assumed liabilities was finalized in August 2024.
Goodwill related to Rookout was primarily attributable to expected synergies and acquired skilled workforce. The goodwill was allocated to the Company’sone reporting unit. The Company identified developed technology as the sole acquired intangible asset. The estimated fair value of the developed technology was $7.8 million, which was based on a valuation using the income approach. The estimated useful life of the developed technology isseven years. The acquired goodwill and intangible asset were not deductible for tax purposes.
Runecast Solutions Limited
On March 1, 2024, the Company acquired a 100% equity interest in Runecast Solutions Limited (“Runecast”), a provider of software solutions that provide insights for security compliance, vulnerability assessment, and configuration management for complex, on-premises, hybrid and multi-cloud IT environments. This acquisition expanded the Company’s platform from the addition of Runecast’s technology and experienced team.
The purchase consideration consisted of $26.1 million of cash paid at closing and $2.3 million in deferred cash payments for a post-closing purchase price adjustment and a holdback to satisfy potential indemnification claims. For the year ended March 31, 2025, the Company paid $0.1 million for a post-closing purchase price adjustment. The Company is obligated to pay the remaining holdback amount within 15 months after the acquisition date.
In connection with the acquisition of Runecast, $9.0 million of RSAs were issued to the previous owners subject to continuing employment and certain indemnification clauses. For the years ended March 31, 2025 and 2024, the Company recognized $3.7 million and $0.3 million of share-based compensation expense for these RSAs, respectively.
The fair value of the purchase price was allocated to the identifiable assets acquired and assumed acquired as of the acquisition date, with the excess recorded to goodwill. The Company acquired $3.2 million of net assets, including $7.5 million of intangible assets, resulting in goodwill of $25.2 million. The fair value of acquired assets and assumed liabilities was finalized in March 2025.
Goodwill related to Runecast is primarily attributable to expected synergies and acquired skilled workforce. The goodwill was allocated to the Company’sone reporting unit. The Company identified developed technology and customer relationships as the acquired intangible assets. The estimated fair value of the developed technology and customer relationships was $7.3 million and $0.2 million, respectively, which was based on a valuation using the income approach. The estimated useful lives of the developed technology and customer relationships isseven years andfour years, respectively. The acquired goodwill and intangible assets were not deductible for tax purposes.
- Investments and Fair Value Measurements
The following table summarizes the amortized cost, unrealized gains and losses, and fair value of the Company’s available-for-sale investments, including those securities classified within “Cash and cash equivalents” in the consolidated balance sheets (in thousands):
| March 31, 2025 | ||||
|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |
| U.S. treasury securities | $108,045 | $223 | $(12) | $108,256 |
| Corporate debt securities | 22,457 | 71 | (14) | 22,514 |
| Commercial paper | 7,778 | 2 | (1) | 7,779 |
| U.S. government agency securities | 12,744 | 2 | (3) | 12,743 |
| Total | $151,024 | $298 | $(30) | $151,292 |
| March 31, 2024 | ||||
|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |
| U.S. treasury securities | $149,978 | $— | $(229) | $149,749 |
As of March 31, 2025, the fair values of available-for-sale investments, excluding those securities classified within “Cash and cash equivalents” in the consolidated balance sheets, by remaining contractual maturity are as follows (in thousands):
| Due within one year | $96,189 |
|---|---|
| Due in one year through five years | 50,934 |
| Total | $147,123 |
Effective January 1, 2024, the Company offers a non-qualified deferred compensation plan to eligible U.S. employees. The Company held $0.7 million and $0.1 million of mutual funds that are associated with this plan and were classified as restricted trading securities as of March 31, 2025 and 2024, respectively. These securities are not included in the tables above but are included as investments in the consolidated balance sheets.
The following tables present the Company’s financial assets that have been measured at fair value on a recurring basis as of March 31, 2025 and 2024, and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value (in thousands):
| March 31, 2025 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Cash equivalents: | ||||
| Money market funds | $679,675 | $— | $— | $679,675 |
| U.S. treasury securities | — | 1,577 | — | 1,577 |
| Commercial paper | — | 1,596 | — | 1,596 |
| U.S. government agency securities | — | 996 | — | 996 |
| Investments: | ||||
| Mutual funds | 714 | — | — | 714 |
| U.S. treasury securities | — | 106,679 | — | 106,679 |
| Corporate debt securities | — | 22,514 | — | 22,514 |
| Commercial paper | — | 6,183 | — | 6,183 |
| U.S. government agency securities | — | 11,747 | — | 11,747 |
| Total financial assets | $680,389 | $151,292 | $— | $831,681 |
| March 31, 2024 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Cash equivalents: | ||||
| Money market funds | $477,102 | $— | $— | $477,102 |
| U.S. treasury securities | — | 45,610 | — | 45,610 |
| Investments: | ||||
| Mutual funds | 102 | — | — | 102 |
| U.S. treasury securities | — | 104,139 | — | 104,139 |
| Total financial assets | $477,204 | $149,749 | $— | $626,953 |
The Company recorded interest income from its cash, cash equivalents, and investments of $49.3 million, $38.7 million, $11.1 million for the years ended March 31, 2025, 2024, and 2023, respectively.
- Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following (in thousands):
| March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Prepaid expenses | $59,552 | $46,435 |
| Income taxes refundable | 11,576 | 10,839 |
| Other | 12,773 | 9,475 |
| Prepaid expenses and other current assets | $83,901 | $66,749 |
- Property and Equipment, Net
The following table summarizes, by major classification, the components of property and equipment (in thousands):
| March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Computer equipment and software | $37,841 | $33,591 |
| Furniture and fixtures | 19,815 | 15,334 |
| Leasehold improvements | 58,627 | 45,742 |
| Other | 12,584 | 9,990 |
| Total property and equipment | 128,867 | 104,657 |
| Less: accumulated depreciation and amortization | (67,345) | (51,332) |
| Property and equipment, net | $61,522 | $53,325 |
Depreciation of property and equipment totaled $19.2 million, $15.5 million, and $12.5 million for the years ended March 31, 2025, 2024, and 2023, respectively.
- Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill on a consolidated basis for fiscal 2025 consists of the following (in thousands):
| March 31, 2025 | |
|---|---|
| Balance, beginning of year | $1,335,494 |
| Foreign currency impact | 941 |
| Balance, end of year | $1,336,435 |
Intangible assets, net, excluding goodwill, consists of the following (in thousands):
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Weighted Average Useful Life (in months) | |
|---|---|---|---|---|
| Capitalized software | $221,966 | $(196,582) | $25,384 | 103 |
| Customer relationships | 351,761 | (351,611) | 150 | 120 |
| Trademarks and tradenames | 55,003 | (55,003) | — | 120 |
| Total intangible assets | $628,730 | $(603,196) | $25,534 |
| Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Weighted Average Useful Life (in months) | |
|---|---|---|---|---|
| Capitalized software | $218,529 | $(181,220) | $37,309 | 103 |
| Customer relationships | 351,756 | (341,087) | 10,669 | 120 |
| Trademarks and tradenames | 55,003 | (51,986) | 3,017 | 120 |
| Total intangible assets | $625,288 | $(574,293) | $50,995 |
Amortization of intangible assets totaled $28.9 million, $39.4 million, and $42.1 million for the years ended March 31, 2025, 2024, and 2023, respectively.
As of March 31, 2025, the estimated future amortization expense of the Company’s intangible assets is as follows (in thousands):
| Fiscal Years Ending March 31, | Amount |
|---|---|
| 2026 | $5,345 |
| 2027 | 5,344 |
| 2028 | 5,340 |
| 2029 | 4,432 |
| 2030 | 3,173 |
| Thereafter | 1,900 |
| Total | $25,534 |
- Income Taxes
Income tax provision
Income before income taxes includes the following (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Domestic | $138,333 | $82,033 | $63,869 |
| Foreign | 85,096 | 72,882 | 26,098 |
| Total | $223,429 | $154,915 | $89,967 |
The income tax provision includes the following (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Current tax position: | |||
| Federal | $93,563 | $44,568 | $11,947 |
| State | 5,530 | (6,236) | 8,071 |
| Foreign | 33,729 | 21,839 | 15,335 |
| Total current tax position | 132,822 | 60,171 | 35,353 |
| Deferred tax provision: | |||
| Federal | (58,527) | (52,712) | (50,345) |
| State | (4,201) | (3,500) | (1,689) |
| Foreign | (330,349) | (3,676) | (1,311) |
| Total deferred tax provision | (393,077) | (59,888) | (53,345) |
| Total income tax (benefit) expense | $(260,255) | $283 | $(17,992) |
During the year ended March 31, 2025, the Company completed an intra-entity asset transfer of the global economic rights of Dynatrace IP from a wholly-owned U.S. subsidiary to a wholly-owned Swiss subsidiary, more closely aligning the Company’s IP rights with its business operations (the “IP Transfer”). The transaction is taxable in the U.S. over a 20-year period. In Switzerland, the transaction resulted in a step-up of tax-deductible basis in the transferred assets, and accordingly, created a temporary difference where the tax basis exceeded the financial statement basis of such intangible assets, which resulted in the recognition of a tax benefit and related deferred tax asset of $320.9 million. The Company determined the estimated value of the transferred IP based principally on the present value of projected income related to the IP, requiring management to make significant assumptions related to the discount rate and the forecast of future revenues and expenses. The tax-deductible amortization related to the transferred IP rights will be recognized over 10 years. The deferred tax asset and the tax benefit were measured based on the enacted tax rates expected to apply in the years the asset is expected to be realized. The Company expects to realize the deferred tax asset resulting from the IP Transfer.
The Company’s income tax expense (benefit) differs from the amounts computed by applying the U.S. federal income tax rate of 21% for the years ended March 31, 2025, 2024 and 2023 to pre-tax income, as a result of the following (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Income tax expense at U.S. federal statutory income tax rate | $46,920 | $32,532 | $18,893 |
| State and local tax expense, net of federal benefits | 7,296 | 306 | 1,421 |
| Foreign tax rate differential | 2,129 | 3,318 | 1,770 |
| U.S. effects of foreign branch income | 12,147 | 8,662 | 1,519 |
| Non-taxable income and non-deductible expenses | 860 | 1,742 | 1,216 |
| Tax credits | (58,761) | (41,740) | (26,457) |
| GILTI inclusion and FDII deduction | (14,563) | (13,905) | (10,938) |
| Employee compensation | 8,622 | (7,188) | 5,528 |
| Changes in uncertain tax positions | 6,534 | (14,835) | 10,978 |
| Changes in valuation allowance | 27,116 | 13,080 | (32,629) |
| Foreign withholding tax | 18,414 | 18,469 | 12,598 |
| Inflation and currency related adjustments | 100 | 851 | (1,518) |
| Intra-entity transfer of IP | (320,902) | — | — |
| Other adjustments | 3,833 | (1,009) | (373) |
| Total income tax (benefit) expense | $(260,255) | $283 | $(17,992) |
Management’s analysis of all available positive and negative evidence as of March 31, 2025 resulted in the conclusion that the net deferred tax assets related to U.S. state and local jurisdictions, with the exception of certain state attributes, are more likely than not to be utilized. As such, the valuation allowance previously recorded against such net deferred tax assets has been reversed accordingly, resulting in a net income tax benefit of $4.8 million.
As of March 31, 2025, the Company continues to maintain a valuation allowance of $38.7 million with respect to certain U.S. federal and state deferred tax assets that, due to their nature, are not likely to be realized. In addition, the Company continues to maintain a valuation allowance of $29.5 million with respect to its deferred tax assets in certain non-U.S. jurisdictions. The net change in the valuation allowance during the year ended March 31, 2025 was $27.7 million, of which $27.1 million impacted tax expense.
Temporary differences and carryforwards that give rise to a significant portion of deferred tax assets and liabilities are as follows (in thousands):
| March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Deferred tax assets: | ||
| Deferred revenue | $32,055 | $26,088 |
| Capitalized research and development costs | 155,368 | 106,836 |
| Accrued expenses | 21,829 | 20,284 |
| Share-based compensation | 28,012 | 28,518 |
| Operating lease liabilities | 24,249 | 14,892 |
| Net operating loss carryforwards | 24,312 | 10,998 |
| Intangible assets | 303,835 | — |
| Tax credit carryforwards | 59,599 | 29,822 |
| Other | 4,683 | 3,070 |
| Total deferred tax assets | 653,942 | 240,508 |
| Valuation allowance | (68,222) | (40,530) |
| Total deferred tax assets, net valuation allowance | 585,720 | 199,978 |
| Deferred tax liabilities: | ||
| Intangible assets | — | 12,880 |
| Operating lease right-of-use assets | 22,267 | 12,826 |
| Deferred commissions | 33,632 | 33,798 |
| Other | 690 | 2,651 |
| Total deferred tax liabilities | 56,589 | 62,155 |
| Net deferred tax assets | $529,131 | $137,823 |
At March 31, 2025, the Company had non-U.S. net operating loss carryforwards of $133.8 million, of which $91.2 million expire in periods through 2045 if not utilized, and the remaining balance of $42.6 million may be carried forward indefinitely. The Company also had non-U.S. tax credit carryforwards of $19.3 million, of which $19.1 million expire in periods through 2030 if not utilized, and the remaining balance of $0.2 million may be carried forward indefinitely. Deferred tax assets of $26.2 million related to non-U.S. net operating losses and tax credit carryforwards are subject to valuation allowances as of March 31, 2025.
At March 31, 2025, the Company had U.S. state and local net operating loss carryforwards of $45.5 million, of which $41.3 million expire in periods through 2043 if not utilized, and the remaining balance of $4.2 million may be carried forward indefinitely. The Company also had U.S. federal tax credit carryforwards of $40.3 million, which expire in periods through 2035. Deferred tax assets of $38.7 million primarily related to U.S. federal tax credit carryforwards are subject to valuation allowances as of March 31, 2025.
During the fiscal year ended March 31, 2025, the Company made the determination that the unremitted foreign earnings associated with certain of its foreign subsidiaries are no longer indefinitely reinvested as a result of the IP Transfer. The Company recorded a deferred tax liability of $0.1 million related to the taxes expected to be imposed upon the repatriation of these unremitted foreign earnings that are not considered indefinitely reinvested. The Company has not provided for taxes on the excess of the amount for financial reporting over the tax basis of investments in certain other foreign subsidiaries in which the Company maintains its assertion that it intends these earnings to be indefinitely reinvested. Generally, these earnings will be treated as previously taxed income from either the one-time transition tax or GILTI, or they will be offset with a 100% dividend received deduction. The income taxes applicable to repatriating such earnings are not readily determinable.
Uncertain tax positions
The amount of gross unrecognized tax benefits (“UTBs”) was $20.2 million and $13.7 million as of March 31, 2025 and 2024, respectively, all of which would favorably affect the Company’s effective tax rate if recognized in future periods.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits for the years ended March 31, 2025, 2024, and 2023 (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Gross unrecognized tax benefit, beginning of year | $13,668 | $29,110 | $15,017 |
| Gross increases to tax positions for the current period | 6,725 | — | — |
| Gross increases to tax positions for prior periods | 1,689 | 721 | 16,471 |
| Gross decreases to tax positions for prior periods | — | (4,277) | (808) |
| Decreases related to settlements | — | (168) | (625) |
| Decreases due to lapse of statutes of limitations | (1,922) | (11,689) | (832) |
| Foreign currency translation | $8 | $(29) | $(113) |
| Gross unrecognized tax benefit, end of year | $20,168 | $13,668 | $29,110 |
As of March 31, 2025 and 2024, the net interest and penalties payable associated with uncertain tax positions was $0.9 million and $1.1 million, respectively. During the years ended March 31, 2025, 2024, and 2023, the Company recognized a benefit of $0.3 million, $1.4 million, and expense of $1.0 million, respectively, related to interest and penalties.
The Company files tax returns in U.S. federal, state, and foreign jurisdictions and the tax returns are subject to examination by various domestic and international tax authorities. As of March 31, 2025, the Company has open U.S. federal tax years back to fiscal year 2022. The Company also has open years in certain significant state jurisdictions back to fiscal year 2019, and foreign jurisdictions back to 2015. These open years contain matters that could be subject to differing interpretations of applicable tax laws and regulations due to the amount, timing or inclusion of revenue and expenses. It is reasonably possible that approximately $3.0 million of certain U.S. and foreign UTBs may be recognized within the next 12 months as a result of a lapse in the statute of limitations.
- Accrued Expenses
Accrued expenses, current consists of the following (in thousands):
| March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Accrued employee - related expenses | $127,712 | $127,100 |
| Accrued tax liabilities | 47,591 | 45,234 |
| Income taxes payable | 25,007 | 18,741 |
| Other | 52,193 | 42,600 |
| Total accrued expenses, current | $252,503 | $233,675 |
- Long-term Debt
On December 2, 2022, the Company entered into a Credit Agreement for a senior secured revolving credit facility (as amended to date, the “Credit Facility”) in an aggregate amount of $400.0 million. The Credit Facility has sublimits for swing line loans up to $30.0 million and for the issuance of standby letters of credit in a face amount up to $45.0 million. The Credit Facility will mature on December 2, 2027. As of March 31, 2025 and 2024, there wereno amounts outstanding under the Credit Facility. There were $0.8 million of letters of credit issued as of March 31, 2025 and 2024. The Company had $399.2 million of availability under the Credit Facility as of March 31, 2025 and 2024.
Borrowings under the Credit Facility are available in U.S. dollars, Euros, Pounds Sterling and Canadian dollars, with a sublimit of $100.0 million for non-U.S. dollar-denominated borrowings. Borrowings under the Credit Facility currently bear interest at (i) the Term Secured Overnight Financing Rate plus 0.10%, (ii) the Adjusted Euro Interbank Offer Rate, (iii) the Canadian Overnight Repo Rate Average, (iv) the Base Rate, as defined per the Credit Facility, or (v) the Sterling Overnight Index Average, in each case plus an applicable margin as defined per the Credit Agreement. Interest payments are due quarterly, or more frequently, based on the terms of the Credit Facility.
The Company incurs fees with respect to the Credit Facility, including (i) a commitment fee ranging from 0.175% to 0.35% per annum, dependent on the Company’s leverage ratio, as defined per the Credit Facility, of the unused commitment under the Credit Facility; (ii) a fronting fee of 0.125% per annum of the face amount of each letter of credit; (iii) a participation fee equal to the applicable margin, as defined per the Credit Facility, applied to the daily average face amount of letters of credit; and (iv) customary administrative fees.
Debt issuance costs of $1.9 million were incurred in connection with the Credit Facility. The debt issuance costs are included within “Other assets” in the consolidated balance sheets and are being amortized into interest expense over the contractual term of the Credit Facility. There were $1.0 million and $1.4 million of unamortized debt issuance costs as of March 31, 2025 and 2024, respectively.
Pursuant to the Credit Facility, obligations owed under the Credit Facility are secured by a first priority security interest on substantially all assets of Dynatrace LLC and other wholly owned subsidiaries of the Company, including a pledge of the capital stock and other equity interests of certain subsidiaries. Under certain circumstances, the guarantees may be released without action by, or consent of, the administrative agent of the Credit Facility. The Credit Facility contains customary affirmative and negative covenants, including financial covenants that require the Company to maintain specified financial ratios. At March 31, 2025, the Company was in compliance with all applicable covenants.
Former first lien credit facilities
The Company’s former First Lien Credit Agreement, as amended, provided for a term loan facility (the “First Lien Term Loan”) in an aggregate principal amount of $950.0 million and a senior secured revolving credit facility (the “Revolving Facility”) in an aggregate amount of $60.0 million. The Revolving Facility included a $25.0 million letter of credit sub-facility. Borrowings under the First Lien Term Loan and the Revolving Facility bore interest, at the Company’s election, at either (i) the Alternative Base Rate, as defined per the credit agreement, plus 1.25% per annum, or (ii) LIBOR plus 2.25% per annum. The maturity date on the First Lien Term Loan and Revolving Facility was August 23, 2025 and August 23, 2023, respectively, with payment due in full on the maturity date.
The incurred debt issuance costs and original issuance discount are recorded as a reduction of the debt balance in the consolidated balance sheets and were amortized into interest expense over the term of the loans. The Company recognized $1.4 million of amortization of debt issuance costs and original issuance discount for the year ended March 31, 2023, which is included in the accompanying consolidated statements of operations.
During the year ended March 31, 2023, the Company terminated the First Lien Credit Agreement and repaid all outstanding borrowings, including accrued interest. The Company recognized a loss on debt extinguishment of $5.9 million within “Interest income (expense), net” in the consolidated statements of operations for the year ended March 31, 2023.
Interest expense
For the years ended March 31, 2025, 2024, and 2023, the Company recognized $1.0 million, $1.4 million, and $8.6 million in interest expense and amortization of debt issuance costs and original issuance discount, respectively.
- Leases
The Company leases office space under non-cancelable operating leases which expire at various dates from fiscal 2026 to 2035. As of March 31, 2025, the weighted average remaining lease term was 6.1 years and the weighted average discount rate was 4.2%. The Company does not have any finance leases.
The following table presents information about leases on the consolidated statements of operations (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating lease expense (1) | $15,282 | $15,522 | $12,908 |
| Short-term lease expense | $2,591 | $2,033 | $1,847 |
| Variable lease expense | $1,412 | $1,585 | $891 |
(1)Presented gross of sublease income.
The following table presents supplemental cash flow information about the Company’s leases (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash paid for amounts included in the measurement of lease liabilities | $19,950 | $18,908 | $16,098 |
| Operating lease assets obtained in exchange for new operating lease liabilities | $21,198 | $10,470 | $24,323 |
As of March 31, 2025, remaining maturities of lease liabilities were as follows (in thousands):
| Fiscal Years Ending March 31, | Amount |
|---|---|
| 2026 | $16,690 |
| 2027 | 15,488 |
| 2028 | 12,065 |
| 2029 | 11,052 |
| 2030 | 10,293 |
| Thereafter | 19,661 |
| Total operating lease payments | 85,249 |
| Less: imputed interest | (9,886) |
| Total operating lease liabilities | $75,363 |
As of March 31, 2025, the Company had commitments of $97.0 million for operating leases that have not yet commenced, and therefore are not included in the right-of-use assets or operating lease liabilities. These operating leases are expected to commence during fiscal year 2026, with lease terms ranging from 8 to 10 years.
- Commitments and Contingencies
Legal matters
The Company is, from time to time, party to legal proceedings and subject to claims in the ordinary course of business. Although the outcome of legal proceedings and claims cannot be predicted with certainty, the Company currently believes that the resolution of any such matters will not have a material adverse effect on its business, operating results, financial condition, or cash flows.
Contractual commitments
The following table summarizes the Company’s contractual commitments as of March 31, 2025 (in thousands):
| Total | |
|---|---|
| Operating lease payments (1) | $182,295 |
| Other commitments | 600,502 |
| Total contractual commitments | $782,797 |
(1)Includes commitments for operating leases that have not yet commenced.
- Shareholders’ Equity
Share Repurchase Program
In May 2024, the Company announced a share repurchase program for up to $500 million of common stock. The share repurchase program does not have a time limit, does not obligate the Company to acquire a specific number of shares, and may be suspended, modified, or terminated at any time, without prior notice. Repurchases may be made from time to time on the open market, pursuant to 10b5-1 trading plans, or by other legally permissible means.
For the year ended March 31, 2025, the Company repurchased and retired 3.4 million shares of its common stock for a total of $172.6 million. As of March 31, 2025, $327.4 million remained available for future repurchases.
- Share-based Compensation
The following table summarizes the components of total share-based compensation expense included in the consolidated statements of operations for each period presented (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cost of revenue | $36,924 | $26,622 | $18,383 |
| Research and development | 100,866 | 69,543 | 41,406 |
| Sales and marketing | 77,336 | 65,762 | 51,147 |
| General and administrative | 56,577 | 46,969 | 35,938 |
| Total share-based compensation expense | $271,703 | $208,896 | $146,874 |
The total income tax benefit recognized in the consolidated statements of operations for share-based compensation arrangements was $68.5 million, $64.1 million, and $38.1 million for the years ended March 31, 2025, 2024, and 2023, respectively.
Amended and Restated 2019 Equity Incentive Plan
In July 2019, the Company’s board of directors (the “Board”), upon the recommendation of the compensation committee of the Board, adopted the 2019 Equity Incentive Plan (the “2019 Plan”) which was subsequently approved by the Company’s stockholders and was later amended and restated by the Board in January 2021.
The Company initially reserved 52,000,000 shares of common stock for the issuance of awards under the 2019 Plan. The 2019 Plan provides that the number of shares reserved and available for issuance under the plan automatically increases each April 1 by 4% of the outstanding number of shares of the Company’s common stock on the immediately preceding March 31 or such lesser number determined by the compensation committee. This number is subject to adjustment in the event of a stock split, stock dividend or other change in the Company’s capitalization. As of March 31, 2025,56,719,444 shares of common stock were available for future issuance under the 2019 Plan.
The awards granted under the 2019 Plan have varying terms but generally vest over athree- orfour-year period, upon satisfaction of a service-based vesting condition, with 33% and 25% vestingone year after the grant date and the remaining vesting ratably on a quarterly basis overtwo andthree years forthree-year andfour-year grants, respectively. From time to time, the Company also grants performance-based and market-based awards to certain key employees that generally vest over athree- orfour-year period upon satisfaction of certain financial performance and relative total stockholder return performance targets established and approved by the Company’s Board for each fiscal year.
Stock options
The following table summarizes activity for stock options during the period ended March 31, 2025:
| Number of Options | Weighted AverageExercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | |
|---|---|---|---|---|
| (in thousands) | (per share) | (years) | (in thousands) | |
| Balance, March 31, 2024 | 3,063 | $22.56 | 5.6 | $73,903 |
| Exercised | (932) | 22.52 | ||
| Forfeited or expired | (59) | 40.12 | ||
| Balance, March 31, 2025 | 2,072 | $22.07 | 4.6 | $52,286 |
| Options vested and expected to vest at March 31, 2025 | 2,072 | $22.07 | 4.6 | $52,286 |
| Options vested and exercisable at March 31, 2025 | 2,068 | $22.03 | 4.6 | $52,286 |
There wereno options granted during fiscal 2025, 2024, or 2023. The aggregate intrinsic value of options exercised during fiscal 2025, 2024, and 2023 was $28.1 million, $46.1 million, and $37.9 million, respectively. The grant date fair value of options vested during fiscal 2025, 2024, and 2023 was $1.6 million, $9.1 million, and $16.7 million, respectively.
As of March 31, 2025, the total unrecognized compensation expense related to non-vested stock options was $0.1 million and is expected to be recognized over a weighted average period of 0.2 years.
Restricted shares and units
The following table provides a summary of the changes in the number of RSAs and RSUs for the year ended March 31, 2025:
| Number of RSAs | Weighted AverageGrant Date Fair Value | Number of RSUs | Weighted Average Grant Date Fair Value | |
|---|---|---|---|---|
| (in thousands) | (per share) | (in thousands) | (per share) | |
| Balance, March 31, 2024 | 142 | $49.05 | 9,852 | $48.17 |
| Granted | — | — | 6,541 | 48.27 |
| Vested | (47) | 49.05 | (5,228) | 48.12 |
| Forfeited | — | — | (1,141) | 47.62 |
| Balance, March 31, 2025 | 95 | $49.05 | 10,024 | $48.33 |
RSUs outstanding as of March 31, 2025 were comprised of 9.0 million RSUs with only service conditions and 1.0 million RSUs with both service and performance or market-based conditions (“PSUs”).
During the year ended March 31, 2025, the Company granted PSUs that contain financial performance conditions (the “Financial PSUs”) and PSUs based on relative total stockholder return performance (the “rTSR PSUs”). Both the Financial PSUs and rTSR PSUs are not earned if the applicable threshold percentage of the specific metric is not achieved. The maximum number of shares that may be earned is 200% of the target award. The PSUs are also subject to time-based vesting and are contingent upon the employee remaining employed by the Company or one of its subsidiaries through the applicable vesting date.
The Financial PSUs generally vest 33%one year after the grant date and the remaining 67% vest ratably on a quarterly basis over the followingtwo years. The number of shares that may be earned pursuant to the Financial PSUs is based on specific Company metrics related to the Company’s fiscal year ending March 31, 2025.
The rTSR PSUs generally vest 33% annually after the grant date. The number of shares that may be earned pursuant to the rTSR PSUs is based on the Company’s stock price performance relative to companies that are the constituents of the Russell 3000 index over performance periods of one, two, and three fiscal years that began on April 1, 2024.
The Company estimated the fair value of rTSR PSUs on grant date using the Monte Carlo simulation model with the following assumptions:
| Fiscal Year Ended March 31, | |
|---|---|
| 2025 | |
| Expected dividend yield | — |
| Expected volatility of the Company | 44.5% - 44.8% |
| Average expected volatility of peer group | 48.5% - 49.2% |
| Expected term (years) | 0.6 - 2.8 |
| Risk-free interest rate | 3.9% - 4.5% |
The Company has not paid and does not expect to pay dividends. Consequently, the Company uses an expected dividend yield ofzero. The expected volatility of the Company is based on the historical volatility of the Company’s common stock and the average expected volatility of the peer group is based on the average historical volatility of the constituents of the Russell 3000 index. The computation of expected term is based upon the remaining term of each performance period upon grant date. The risk-free interest rate is based on the continuously compounded U.S. Treasury yield curve in effect at the time of grant that corresponds with the longest remaining performance period.
The weighted average grant-date fair value of RSUs granted during fiscal 2025, 2024, and 2023 was $48.27, $51.60, and $40.42, respectively. The weighted average grant-date fair value of RSAs granted during fiscal 2024 was $49.05. There wereno RSAs granted during the years ended March 31, 2025 and 2023.
The aggregate fair value of RSAs vested during fiscal 2025, 2024, and 2023 was $2.7 million, $0.2 million, and $6.8 million, respectively. The aggregate fair value of RSUs vested during fiscal 2025, 2024, and 2023 was $266.7 million, $220.3 million, and $82.1 million, respectively.
As of March 31, 2025, the total unrecognized compensation expense related to unvested RSAs is $5.0 million and is to be recognized over a weighted average period of 1.9 years. As of March 31, 2025, the total unrecognized compensation expense related to unvested RSUs was $378.0 million and is expected to be recognized over a weighted average period of 2.0 years.
Employee Stock Purchase Plan
In July 2019, the Board adopted, and the Company’s stockholders approved, the 2019 Employee Stock Purchase Plan (“ESPP”). The Company offers, sells and issues shares of common stock under this ESPP from time to time based on various factors and conditions, although the Company is under no obligation to sell any shares under this ESPP. The ESPP provides that the number of shares reserved and available for issuance under the plan will automatically increase each April 1 by lesser of (i)1% of the outstanding number of shares of the Company’s common stock on the immediately preceding March 31, (ii)3,500,000 shares of common stock, or (iii) such lesser number determined by the compensation committee. The ESPP provides forsix-month offering periods and each offering period consists ofsix-month purchase periods. On each purchase date, eligible employees purchase shares of the Company’s common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s common stock on the offering date or (2) the fair market value of the Company’s common stock on the purchase date. For the year ended March 31, 2025,531,301 shares of common stock were purchased under the ESPP. As of March 31, 2025,18,303,111 shares of common stock were available for future issuance under the ESPP.
As of March 31, 2025, there was approximately $1.3 million of unrecognized share-based compensation related to the ESPP that is expected to be recognized over the remaining term of the current offering period.
The Company estimated the fair value of the ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions:
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Expected dividend yield | — | — | — |
| Expected volatility | 27.1% - 32.2% | 32.2% - 51.6% | 35.4% - 64.3% |
| Expected term (years) | 0.5 | 0.5 | 0.5 |
| Risk-free interest rate | 4.3% - 5.4% | 4.7% - 5.4% | 0.1% - 4.7% |
The Company has not paid and does not expect to pay dividends. Consequently, the Company uses an expected dividend yield ofzero. Beginning in May 2022, the expected volatility is based on the historical volatility of the Company’s common stock. Prior to May 2022, the computation of expected volatility was based on a calculation using the historical volatility of a group of publicly traded peer companies. The computation of expected term was based on the offering period, which issix months. The risk-free interest rate is based on the U.S. Treasury yield curve that corresponds with the expected term at the time of grant.
- Net Income Per Share
The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Numerator: | |||
| Net income | $483,684 | $154,632 | $107,959 |
| Denominator: | |||
| Weighted average shares outstanding, basic | 298,384 | 294,051 | 287,700 |
| Dilutive effect of share-based awards | 5,218 | 5,229 | 3,917 |
| Weighted average shares outstanding, diluted | 303,602 | 299,280 | 291,617 |
| Net income per share, basic | $1.62 | $0.53 | $0.38 |
| Net income per share, diluted | $1.59 | $0.52 | $0.37 |
The effect of certain common share equivalents were excluded from the computation of weighted-average diluted shares outstanding for the years ended March 31, 2025, 2024, and 2023 as inclusion would have resulted in anti-dilution. A summary of these weighted-average anti-dilutive common share equivalents is provided in the table below (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Stock options | 74 | 130 | 952 |
| Unvested RSAs and RSUs | 209 | 203 | 776 |
- Employee Benefit Plan
The Company has established a 401(k) tax-deferred savings plan (the “401(k) Plan”), which permits participants to make contributions by salary deduction pursuant to Section 401(k) of the Internal Revenue Code. The Company is responsible for administrative costs of the 401(k) Plan and may, at its discretion, make matching contributions to the 401(k) Plan. In addition, the Company offers defined contribution plans to employees in certain countries outside the U.S and as of January 2024, a non-qualified deferred compensation plan to certain eligible employees. For the years ended March 31, 2025, 2024, and 2023, the Company made contributions of $7.9 million, $7.0 million and $6.3 million to the U.S. 401(k) Plan, respectively.
- Segment and Geographic Information
The Company’s CODM is its Chief Executive Officer. The CODM uses consolidated net income for purposes of making operating decisions, assessing financial performance and allocating resources in the budget and forecasting process and budget-to-actual reviews. As such, the Company has determined that it operates asone operating and reportable segment.
The CODM also utilizes expense information in order to assess the Company’s financial performance. The Company’s significant expenses and other segment items, as included in consolidated net income, are provided in the table below (in thousands):
| Fiscal Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Revenue | $1,698,683 | $1,430,530 | $1,158,530 |
| Adjusted cost of revenue(1) | 267,559 | 221,508 | 187,766 |
| Adjusted research and development expenses(1) | 276,582 | 229,724 | 175,239 |
| Adjusted sales and marketing expenses(1) | 523,919 | 463,288 | 393,198 |
| Adjusted general and administrative expenses(1) | 137,083 | 117,771 | 110,536 |
| Share-based compensation and related employer payroll taxes | 287,147 | 222,884 | 153,065 |
| Amortization of intangibles | 26,802 | 38,558 | 41,856 |
| Other segment items(2) | (304,093) | (17,835) | (11,089) |
| Segment net income | $483,684 | $154,632 | $107,959 |
| Consolidated net income | $483,684 | $154,632 | $107,959 |
(1) Excludes share-based compensation; employer payroll taxes on employee stock transactions; amortization of intangibles; and transaction, restructuring and other-non-recurring or unusual items, which are independently reviewed by the CODM.
(2)Other segment items primarily includes interest income (expense), net; other (expense) income, net; and income tax benefit (expense), as reported in the consolidated statements of operations. Other segment items also includes $0.2 million, $8.4 million, and $4.1 million of transaction, restructuring and other-non-recurring or unusual items for the years ended March 31, 2025, 2024, and 2023, respectively.
The measure of segment assets is the total assets as reported in the consolidated balance sheets.
Revenue
Revenues by geography are based on the region of the Company’s contracting entity. Refer to Note 3, Revenue Recognition, for a disaggregation of revenue by geographic region.
Long-lived assets, net
The following table presents the Company’s net long-lived assets, which consists of property and equipment, net, and operating lease right-of-use asset, net, by geographic region for the periods presented (in thousands):
| March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| North America | $36,522 | $35,339 |
| Europe, Middle East and Africa | 88,255 | 73,892 |
| Asia Pacific | 3,577 | 5,041 |
| Latin America | 647 | 443 |
| Total long-lived assets, net | $129,001 | $114,715 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.